Join Our Email List Receive FREE SUMMARY OF THE CHINA STUDY
What this vaccine is in reality a genetically modified virus
August 17, 2009
The truth about the pandemic flu vaccines
What you need to know and are afraid to ask
By Cynthia A. Janak
Around the world, especially in India, the doom and gloom people are telling us that it is going to be catastrophic this fall in the northern hemisphere in regards to cases of the flu. What they are not telling you is that the cases are mild for the majority of the population.
The other thing is that according to the UK experts at the National Institute for Medical Research mentioned that "Analysis done so far suggests what they are dealing with is a mild virus." "It is believed that a further mutation would be needed in order for the H1N1 virus to cause the mass deaths that have been estimated by some."
"The swine flu strain is a H1N1 virus, the same type as seasonal flu which circulates throughout the world every year, and kills roughly 0.1% of those infected or higher in an epidemic year."
"Professor Wendy Barclay, chair in influenza virology at Imperial College London says initial indications suggest there is nothing about the genetic make-up of the new virus which is a cause for particular concern." http://news.bbc.co.uk/2/hi/health/8028371.stm
The average flu in the United States claims according to the CDC 36,000 people a year. The majority of those people had a pre-existing condition that weakened them and made them more susceptible to the virus.
In this article I am not going to give you all the media reports. I am going to give you the facts behind what you can expect this fall. Look at it this way. When you line up to get your series of flu shots which is going to be either 3 or 4 spaced 2 to 3 weeks apart you will know exactly what is in them. You will look at the syringe that is going to go into the arm of your child or father or mother and know what chemicals are going to go into their bodies. After you read this you will not be able to say that you did not know what was in that shot or jab as they call it overseas.
It is my opinion, the Gardasil girls were just the testing ground for this type of regimen and now many are disabled.
Well, here you go. Here is the information that you need to know and were afraid to ask.
Since March, 2009, the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), through the news media, have created the impression that a "novel" strain of H1N1 (swine) flu virus has appeared and that it will mutate and spread pandemically all across the world. Deemed "unstoppable," the only way to protect the world's nearly 7 billion people, according to WHO et al, is to "develop" a vaccine, produce nearly five billion doses of it and vaccinate the entire planet — children and pregnant women first.
The evidence, however, shows that the "novel" H1N1 "virus" strain is a product of bio-weapons research and the patented vaccine has been under development for at least four years. The implication of this research undermines the WHO/CDC/media-created impression that a global cooperative of public health officials and vaccine manufacturers are responding appropriately to a pending public health emergency.
CNN reported April 24, 2009 that CDC Influenza Division Director Nancy Cox, PhD, said, "The new virus has genes from North American swine and avian influenza, human influenza, and swine influenza normally found in Asia and Europe."  The next day (April 25, 2009) CNN reported that WHO Epidemic and Pandemic Disease spokesman Gregory Hartl said, "The strain of the virus seen in Mexico is worrisome because it has mutated from older strains."  On May 22, 2009, the World Health Organization's "Weekly Epidemiological Record" noted that, "Most cases [of swine flu] appear to have uncomplicated, typical influenza-like illness and [afflicted individuals] recover spontaneously."  This appears to be patently true, as the CDC admits that reported death rates per thousands of infections are much lower with this "novel virus" than death rates commonly ascribed to "seasonal" influenza.
On June 11, 2009, the WHO Regional Office for Europe announced, "Today WHO raised the level of influenza A(H1N1) pandemic alert to phase 6, as sustained community-level transmission of the virus is taking place in more than one region of the world. The term pandemic means that an influenza virus that is new to human beings has appeared is spreading and is causing disease in many parts of the world. Globally, it is of moderate severity."  Regardless that the epidemiological data, May, 2009, Novartis received a $289 million order from the US Department of Health and Human Services for A(H1N1) vaccine with proprietary adjuvant MF59© 
When a company applies for a patent that means that they have done some research and development of a novel product and they want the rights to that novel product to make money specific to that product for a certain number of years. This is what the dictionary says about patent.
One of the reasons for the creation of this vaccine was to minimize something called "oculorespiratory syndrome" (ORS). What this is per a medical dictionary definition, is "a usually transient syndrome of bilateral red eyes and upper respiratory symptoms, including cough, wheezing, chest discomfort, sore throat, and occasionally facial edema, following influenza vaccination." http://www.medilexicon.com/medicaldictionary.php?t=88625
According to the WHO they found something interesting reported by Canada during the 2000–2001 flu vaccine season. "Characteristically, the onset of symptoms is 2-24 hours after immunization, more commonly in women than in men, and particularly in the age group 40-59 years. First time recipients and subjects with an allergic predisposition are especially susceptible. It is not clear why there is a special predisposition in these subjects." And "Cases of ORS were reported in the 2001 vaccination campaign for both vaccines, and people affected previously appeared to have a relatively higher risk of recurrence with revaccination." http://www.who.int/vaccine_safety/topics/influenza/oculorespiratory_syndrome/en/index.html
My question is this. If it becomes 'required' (mandatory) to have the three to four doses of flu vaccine will the people that 'refuse' (non-compliant) on the basis of 'an allergic predisposition' be instructed (forced) to "self-quarantine" or relocate to an "approved isolation facility"? http://www.hhs.gov/pandemicflu/plan/pdf/HHSPandemicInfluenzaPlan.pdf
Back to the Novartis patent. What we have here is a virus that is obtained by reverse genetics techniques. What this vaccine is in reality a genetically modified virus like particle or virion. They like to call it 'generating reassortant viruses for vaccine preparation.'
In this patent Novartis prefers to grow the virus in either MDCK cells which are derived from Madin Dabry canine kidney, Vero Cells derived from the African Green Monkey kidney, or PER C6 cells derived from human embryonic retinoblasts. So they have a choice here. They are either going to use dog, monkey or embryos for this vaccine. All of which foreign DNA will be a component.
Now, what concerns me here is that GMO (genetically modified organisms) can be harmful. It was reported that in March of 2001, the Center for Disease Control reported that food is responsible for twice the number of illnesses in the U.S. This is around the time we started to eat GM foods. 
The other item is that "Genetic engineers continually encounter unintended side effects — GM plants create toxins, react to weather differently, contain too much or too little nutrients, become diseased or malfunction and die. When foreign genes are inserted, dormant genes may be activated or the functioning of genes altered, creating new or unknown proteins, or increasing or decreasing the output of existing proteins inside the plant. The effects of consuming these new combinations of proteins are unknown." 
Let us go on to the ingredients of this wonderful, life saving, innovative, fully tested, pandemic flu vaccine. NOT
The next preferred ingredient is Squalene. Squalene is an essential lipid (oil). Squalene is a cholesterol precursor, which stimulates the immune system nonspecifically. We demonstrate that one intradermal injection of this adjuvant lipid can induce joint-specific inflammation in arthritis-prone DA rats. Histopathological and immunohistochemical analyses revealed erosion of bone and cartilage, and that development of polyarthritis coincided with infiltration of ß+ T cells. — Our demonstration that an autoadjuvant can trigger chronic, immune-mediated joint-specific inflammation may give clues to the pathogenesis of rheumatoid arthritis, and it raises new questions concerning the role of endogenous molecules with adjuvant properties in chronic inflammatory diseases. 
There is also a "link between the health problems of Gulf-War veterans and possible presence of squalene in vaccines received by these soldiers has been suggested. One published report has suggested that some army veterans who received anthrax vaccines developed anti-squalene antibodies and that these antibodies caused disabilities." 
We are also going to have vitamin E (tocopherol) as one of the emulsion ingredients along with the squalene. There have been studies performed on rats that with a weekly dose "50 mg of a vitamin E concentrate were found to have fatty changes in the liver. In addition, intimal sclerosis of the aorta was seen, with the over-development of collagenous tissue at the base of the aortic valve and in the medial coat of the aorta." 
A study of female Wistar rats it was found that "Vitamin E depressed body-weight gain at concentrations of 10,000 and 25,000 IU/kg diet, and increased relative heart and spleen weights were seen at 8 months and 16 months," 
The next ingredient of concern is Polysorbate 80 which is a surfactant. What a surfactant does in a vaccine environment is keep the ingredients suspended in a somewhat uniform fashion. This is all well and good because you do not need the ingredients to be of different concentrations in different vials or syringes. There is a much larger concern with Polysorbate 80.
There is "a report that shows that neonatal rats were injected with small doses of polysorbate 80 and the results were major effects on the reproductive organs of the rats, resulting in infertility."  There was a study done on pregnant women by PubMed where "in an intravenous vitamin mix given to a pregnant woman who suffered anaphylactic shock where polysorbate 80 was identified as the causative agent," 
It doesn't stop there. Now we have 3-O-deacylated monophosphoryl lipid A (3dMPL) added to the mix. Here we have another lipid. This is what I found on this ingredient. "If MPL is immunogenic, it raises the possibility of a dangerous "cross reaction." The human body is full of lipids. Antibodies and immune cells responding to MPL might also respond to other lipids in the body, thus breaking tolerance for endogenous lipids (those native to the human body) and initiating autoimmunity." 
Now I am going to tell you about my favorite ingredient, Thiomersal or Ethyl mercury. It does not matter what you hear from the main stream media about mercury being in the vaccines because I researched all the vaccines that are approved for a pandemic and many have it in there. It may be only a trace amount but for the majority of vaccines that I have researched it is more than just a trace amount. GlaxoSmithKline uses Thiomersal in all the approved pandemic vaccines that I have found. 
You are also looking at having in these vaccines Sodium Chloride, TromeThamine, L-Histidine, Sodium Borate, Sorbitan Trioleate (Span 85 or Tween 85), Aluminum Salts, Aluminum Hydroxide or QS21 (Saponin).
QS21 sounded like another gem when I read this. "QS-21 induced mild local erythema, induration, and tenderness lasting 24-72h in all patients at the 100-mcg dose. The 200-pg dose of QS-21 was associated with local tenderness and inflammation lasting 2-10days in all patients as well as mild flu-like symptoms, including low grade fever (<38.5°C), headache, and myalgia lasting 8-24h after most immunizations. No neurological abnormalities or other side effects were observed."  Why would they be looking at neurological abnormalities or other side effects? This really bothered me.
That is enough for the Novartis vaccine patent. You have to remember that many of the ingredients will also be present in all the other vaccines especially the ingredient Squalene.
Now I want to tell you about something that happens when you get an inoculation, like they are planning, weeks apart. This is called challenge and re-challenge. I am going to reference published case reports of neurological disease following challenge and re-challenge with a hepatitis B vaccine. 
"The first pertains to a woman diagnosed with leukoencephalitis following each of her second and third shots of recombinant hepatitis B vaccine (Konstantinou et al., 2001)." 
"The second case report pertains to sensorineural deafness (Biacabe et al., 1997). Although the patient appears to have suffered hearing loss twice after vaccination, the time frame is too short to be suggestive of an immunemediated reaction." 
"...tabulation prepared by CDC of case reports submitted to the Vaccine Adverse Events Reporting System (VAERS) between 1990 and 2001 lists eight cases stating evidence of rechallenge adverse events. These included a variety of clinical descriptions, including neuropathy, MS, and brachial neuritis." 
"Reports included 125 cases of MS, 15 cases of brachial neuritis, 83 cases of optic neuritis, 46 cases of peripheral neuritis, 91 cases of GBS, 30 cases of ADEM or demyelinating disease not otherwise specified, and 109 cases of myelitis. Most of these reports were included in only one outcome category, but some (73) were classified in more than one." 
"The published medical literature provides case reports of several demyelinating diseases following hepatitis B vaccination. These range, for example, from optic neuritis in a 28-year-old man (Albitar et al., 1997), to GBS in a 45-year-old woman (Creange et al., 1999), and transverse myelitis in a 40-year-old health care worker (Tartaglino et al., 1995)." 
Here is an animal study using hamsters. "The pathology of Mycoplasma pneumoniae pulmonary infection for a hamster model was examined after whole bacterium rechallenge or component vaccination. Animals which, after an initial infection, were rechallenged with either live or heat-killed M. pneumoniae inocula developed severe early recall lesions in the first 3 days. In contrast, animals infected once develop maximum histopathology at approximately 10-14 days. A severe perivascular inflammatory cellular infiltrate developed in the rechallenged groups, and pulmonary pathology could also be elicited by rechallenge with bacterial growth medium components." 
"Challenge, de-challenge, and re-challenge studies — Challenge, de-challenge and re-challenge studies are useful in suggesting causation. In some cases, however, only a second challenge will result in an AE. Sometime the AE after a challenge is long-lasting and does not exhibit a de-challenge response after the treatment is stopped. Re-challenge can be considered positive when a similar, but not identical, treatment is applied (for example, when another member of the same drug class, a nearly identical vaccine, or a drug with to a shared vaccine component is used)." 
I want to bring your attention to the comment, "only a second challenge will result in an AE" (adverse event). This is what happened with many of the Gardasil girls. They did not have any noticeable symptoms after the first shot but when they received the second or third shot that is when the symptoms manifested themselves. Now many of them are on the GFCF diets, taking vitamins and going to the chiropractor for some relief. They did not experience the "de-challenge" as stated in the previous paragraph. Many of the girls have been having medical problems for over 2 years now and the recovery is very, very slow.
The last item of concern is that the pandemic flu vaccines have been authorized to be co-administered with other vaccines on the schedule. (see Novartis patent) This is of paramount importance to me because as I was researching those vaccines for ingredient content I found more mercury, aluminum and other ingredients. If you add together the amount of ingredients that a person or child will be receiving you have the very real potential to be over the safe limit for the chemicals. 
There you have it, all the information that you really did not want to know about the upcoming immunization program with the pandemic and standard flu vaccines. Now it is up to you to make the decision if you want to get vaccinated with the vaccines that they propose. I know that after all my research which spanned over 2 weeks, over 10 hours a day, I am not going to do it. I guess I am going to be one of those "non-compliant" that is going to be "required" to be "self-quarantined" or put in an "approved isolation facility." I also do not believe in putting foreign chemicals or DNA in my finely balanced body provided by my Creator.
 CDC: Swine flu viruses in U.S. and Mexico match, CNN, April 25, 2009 — Updated 0437 GMT (1237 HKT) http://edition.cnn.com/2009/HEALTH/04/24/swine.flu/index.html
To see actual statement delivered in the Press Briefing Transcripts, CDC Briefing on Public Health Investigation of Human Cases of Swine Influenza, April 23, 2009, 3:30 p.m. EST, http://www.cdc.gov/media/transcripts/2009/t090423.htm
So we have some gene segments that are North American swine influenza viruses. Some gene segments North American avian influenza viruses. One gene segment from a human influenza virus and two gene segments that are normally found from swine influenza viruses in Asia and in Europe.
 More cases of swine flu reported; WHO warns of 'health emergency,' CNN, updated 11:36 p.m. EDT, Sat April 25th, 2009, http://www.cnn.com/2009/HEALTH/04/25/swine.flu/index.html
 Weekly epidemiological record, WHO, May 22nd, 2009, No. 21, 84, 185-196 http://www.who.int/wer/2009/wer8421.pdf
 Influenza A (H1N1): pandemic alert phase 6 declared, of moderate severity, WHO/Europe outbreak update, 11 June 2009, 16:00 GMT http://www.euro.who.int/influenza/AH1N1/20090611_11
 Novartis successfully demonstrates capabilities of cell-based technology for production of A(H1N1) vaccine, Novartis, Media release, June 12, 2009 07:15 CET http://www.novartis.com/newsroom/media-releases/en/2009/1322241.shtml
 Genetically modified vaccines and foods and their dangers. http://www.responsibletechnology.org/GMFree/AboutGMFoods/FAQs/index.cfm
 (American Journal of Pathology. 2000;156:2057-2065.) © 2000 American Society for Investigative Pathology The Endogenous Adjuvant Squalene Can Induce a Chronic T-Cell-Mediated Arthritis in Rats, Barbro C. Carlson*, Åsa M. Jansson*, Anders Larsson , Anders Bucht * and Johnny C. Lorentzen* , From the Department of Medicine,*Unit of Rheumatology, Karolinska Institutet, Stockholm; the Department of Medical Sciences, University Hospital, Uppsala; and the Department of Biomedicine, Division of NBC Defense, Defense Research Establishment, Umeå, Sweden
 (Marxs et al., 1947).
 (Yang & Desai, 1977).
 PubMed.Gov a service of the U.S. Library of Medicine and the National Institute of Health, http://www.ncbi.nlm.nih.gov/pubmed/8473002?dopt=Abstract
 Other pandemic influenza vaccines approved by the EMEA (European Medicines Agency) and their ingredients. http://www.emea.europa.eu/htms/human/pandemicinfluenza/vaccines.htm
 [CANCERRESEARCH55, 2783-278 July 1, 1995], GM2-KLH Conjugate Vaccine: Increased Immunogenicity in Melanoma Patients after Administration with Immunological Adjuvant QS-21, Friedheim Helling,2 Shengle Zhang, Ann Shang, Sucharita Adluri, Michele Calves, Rao Koganty, B. Michael Longenecker, Tzy-J. Yao, Herbert F. Oettgen, and Philip 0. Livingston
 Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders (2002), Board on Health Promotion and Disease Prevention (HPDP), Institute of Medicine (IOM), page 39
 Bases for the early immune response after rechallenge or component vaccination in an animal model of acute Mycoplasma pneumoniae pneumonitis, CIMOLAI N. (1) ; MAH D. G. (1) ; TAYLOR G. P. (1) ; MORRISON B. J. (1) ; 1) Division of Medical Microbiology, Department of Pathology, The University of British Columbia, Vancouver, CANADA
 Drug Injury, Liability, Analysis and Prevention, Second Edition, James T. O'Donnell, Pharm.D., M.S., FCP, ABCP, FACN, CNS, R.Ph., Chapter 10, Evaluation of Medical Causation, Donald H. Marks, M.D., Ph.D., 10.7. Daibert v. Merrell Dow Pharmaceuticals, Inc., and the Evolution of Causation, Page 148
 Vaccines to be administered along with flu vaccines. http://www.fda.gov
© Cynthia A. Janak